Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jenna who wrote (112541)	8/25/2000 5:37:13 PM
From: Jenna	Read Replies (3) of 120523

Teva Pharm 8/24/00 Lehman Brothers sees share (TEVA) price vulnerable to selloff over near term in research note. How come? because they just got FDA approval to sell Enalapril on 8/23? Are Lehman brothers holding Merck and see a problem for TEVA's success maybe influencing MRK shareholders? TEVA is one of the finest companies in the market today, it locked up the generic market across the globe but Lehman sees it vulnerable to a selloff???? Maybe becuase they hold SBH and want a little boost there on the expense of TEVA.. I am no longer in TEVA (for a while) so I have no vested interest here except that I am tired of the influence wielded by no-nothing analysts. We can't do much but at least we should be informed. ********** Teva gets Copaxone approved in Britain JERUSALEM, Aug 13 (Reuters) - Israeli generic drugmaker Teva Pharmaceuticals (NasdaqNM:TEVA - news) said on Sunday it had received approval to market its Copaxone multiple sclerosis treatment in Britan.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next